HTLV-1 and tropical spastic paraparesis. 1. Clinical features, pathology and epidemiology.
The clinical profile of tropical spastic paraparesis (TSP), described in scattered tropical and subtropical territories over the past 30 years, has been more clearly defined since the discovery of its direct association with human T lymphotropic virus type 1 (HTLV-1). A chronic disease of adults, commoner in women, it usually presents as a progressive spastic paraparesis with sphincter disturbance, sometimes with backache and lower limb sensory disorder. Most cases are chair-bound within 10 years. Histology reveals a chronic lymphocytic meningomyelopathy, predominantly in the spinal cord, together with long tract demyelination and hyalinoid thickening of the media and adventitia of small blood vessels. Geographical areas of high prevalence of TSP are known in the Caribbean, South America, South Africa, southern Japan, the Seychelles and probably in India, and it is sparsely endemic elsewhere. The virus appears to exist within lymphocytes for long periods. Vertical transmission occurs postnatally, and sexual and transfusion infection are also recognized, but much remains to be clarified regarding its pathogenesis and epidemiology.
Montgomery
R D
RD
Department of Medicine, East Birmingham Hospital, UK.
D001933:Brain Stem / Q000473:pathology; D005260:Female; D015490:HTLV-I Infections / Q000150:complications* / Q000453:epidemiology / Q000473:pathology; D015368:Human T-lymphotropic virus 1; D006801:Humans; D008297:Male; D009103:Multiple Sclerosis / Q000175:diagnosis; D015493:Paraparesis, Tropical Spastic / Q000453:epidemiology / Q000209:etiology* / Q000473:pathology; D013116:Spinal Cord / Q000473:pathology